The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback